Inventor · disambiguated record
Ralf Wagner
Also filed as: WAGNER RALF
9 granted patents·12 pending applications·92 citations·filing 2000–2022
88Inventor score
Top patents by PatentIndex Score
21 records- 0190US8224578B2Method and device for optimizing a nucleotide sequence for the purpose of expression of a proteinRAAB DAVID·Filed 2003·Granted Jul 17, 2012·45 cites·22 claims
- 0289US8859275B2Method for modulating gene expression by modifying the CpG contentNOTKA FRANK·Filed 2005·Granted Oct 14, 2014·20 cites·17 claims
- 0386US7323557B2Genome of the HIV-1 inter-subtype (C/B') and use thereofGENEART AG·Filed 2006·Granted Jan 29, 2008·7 cites·5 claims
- 0477US7332588B1Genome of the HIV-1 inter-subtype (C/B) and use thereofGENEART AG·Filed 2000·Granted Feb 19, 2008·5 cites·6 claims
- 0576US7378515B2Synthetic gagpol genes and their usesGENEART AG·Filed 2001·Granted May 27, 2008·5 cites·21 claims
- 0674US8691533B2Inducible gene expressionNOTKA FRANK·Filed 2005·Granted Apr 8, 2014·4 cites·5 claims
- 0774US8287881B2Synthetic gagpol genes and their usesWAGNER RALF·Filed 2007·Granted Oct 16, 2012·3 cites·18 claims
- 0872US10273486B2Method for modulating gene expression by modifying the CpG contentGENEART AG·Filed 2014·Granted Apr 30, 2019·1 cites·12 claims
- 0966US2013123483A1Method and device for optimizing a nucelotide sequence for the purpose of expression in a proteinRAAB DAVID·Filed 2012·Application pending·0 cites
- 1063US7767455B2Nucleus export reporter systemGENEART GMBH·Filed 2001·Granted Aug 3, 2010·2 cites·21 claims
- 1161US2014228558A1Method and device for optimizing a nucelotide sequence for the purpose of expression in a proteinGENEART AG·Filed 2013·Application pending·0 cites
- 1260US2021155940A1Method for modulating gene expression by modifying the cpg contentTHERMO FISHER SCIENT GENEART GMBH·Filed 2020·Application pending·0 cites
- 1360US2024408190A1Influenza vaccinesDIOSYNVAX LTD·Filed 2022·Application pending·0 cites
- 1460US2025066427A1Therapeutic papilloma virus vaccinesSIRION BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1559US2025312437A1Coronavirus vaccinesDIOSYNVAX LTD·Filed 2022·Application pending·0 cites
- 1658US2019270999A1Method for modulating gene expression by modifying the cpg contentTHERMO FISHER SCIENT GENEART GMBH·Filed 2019·Application pending·0 cites
- 1753US2016259885A1Method and device for optimizing a nucelotide sequence for the purpose of expression in a proteinTHERMO FISHER SCIENT GENEART GMBH·Filed 2016·Application pending·0 cites
- 1849US2013122585A1Synthetic gagpol genes and their usesWAGNER RALF·Filed 2012·Application pending·0 cites
- 1945US2022040284A1Vaccines and methodsTHE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIV CAMBRIDGE·Filed 2019·Application pending·0 cites
- 2044US2006110403A1Non-human herpesviruses as vectorsBEER MARTIN·Filed 2003·Application pending·0 cites
- 2138US2004161477A1Phyllanthus-derived compounds for the prevention and/or treatment of disease associated with a retrovirusFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ralf Wagner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →